Category: Newsletters

Blue Horseshoe Stocks: NUGN on Bottom-Watch & More

NuGene International, Inc. NUGN

We’re mentioning NUGN for the first time this morning on the heels of some interesting events that have recently unfolded. The stock had been on a sustained uptrend for over two months that was apparently the product of a massive promotion (in which we played no role) which resulted in the PPS running from below $2 to more than $4.

On Wednesday, the company issued a public statement to clarify that it was not involved in promotional activities of any sort >>Read PR

What followed yesterday was a massive sell-off to the tune of nearly 40%, and that’s where we enter the picture. Regardless of the catalysts behind NUGN’s gradual rise and rapid fall, we’re only interested in the chart activity that will follow. We’re going to highlight NUGN as a bottom-watch play, because the resultant bounce when the stock finds a solid level of support could make quick-strike gains a snap for those paying close enough attention.

Fresh News Plays

We’re going to tag both of the following for observation today after each published notable premarket PR’s this morning:

AmeriMex International, Inc. AMMX

In addition to announcing the latest in a long string of recently secured purchase agreements (links below), the AMMX chart is looking rather bullish at the moment.

_______

Corbus Pharmaceuticals Holdings, Inc. CRBP

We’ll also keep an eye on CRBP, which has some FDA-related news out today.

Corbus Pharmaceuticals Announces FDA Orphan Drug Designation for Resunab(TM) for the Treatment of Systemic Sclerosis (Scleroderma) (Fri 8:12AM EDT)

Options Idea:

Twitter, Inc. TWTR is responding well in the wake of the revelation that its current CEO will be stepping down on July 1st. We’re going to put TWTR Weekly $36-38 Calls on watch today as well, for potential daytrading opportunities.

Extended Watchlist:
SNSS, OCLS, ESI, OSUR

Blue Horseshoe Stocks: MDCN Recap, Options Idea & More

Medican Enterprises, Inc. MDCN

In yesterday morning’s premarket report we took note of MDCN’s rebound off of a relative bottom, and speculated that the momentum built up in Tuesday’s session could carry over into added gains.

That certainly proved to be the case, as MDCN spiked heavily from its early low of .0024, running as high as .0039 shortly before 11:30AM. It marked an intraday move which provided gain opportunities of up to 62% before pulling back into the close of .0022.

We’ll go ahead and monitor this one for the remainder of the week for any potential bounce-play chances that might arise when it finds solid support. We’ll look for that to occur at or above Tuesday’s low of .0015.

Isis Pharmaceuticals, Inc. ISIS – Options Idea

ISIS appears to be in full-on breakout mode this morning, and as a result we thought we’d formulate an idea to take advantage of this via the options chain.

Given the current price and conditions caused by this morning’s catalyst (link to PR below), we’re going to be tracking the activity in the Weekly $70-73 Calls for potential intraday flip opportunities.

Extended Watchlist:
PTBI, RAD, SFUN, ATOS, AGEN, ASTI

Blue Horseshoe Stocks: LNKD Options Update & More

LinkedIn Corp. LNKD – Options

A week ago today, we formulated some options ideas for LNKD including a range of longer-term contracts for our watchlist, specifically August $220.00-230.00 Calls. This morning we wanted to give an update on the trading ranges of those contracts and the opportunities they have afforded us thus far.

08/21 $220 Calls – Range: 9.80-14.30 – Max Gain: 46%
08/21 $225 Calls – Range: 8.02-11.30 – Max Gain: 41%
08/21 $230 Calls – Range: 5.10-9.35 – Max Gain: 83%

We want to keep in mind that we essentially have all summer to continue monitoring these contracts. The swings we’ve seen up to this point could just be the tip of the iceberg, so we won’t let LNKD slip off of our radars. The stock has been on a steady rebound from recent lows since the end of May. We’ll be looking for it to continue to building the chart with higher highs and higher lows; key resistance is presently sitting at the 50DMA of 226.39.

Medican Enterprises, Inc. MDCN

We also need to remind our readers of a recent bottom-watch call we made in the form of MDCN. This cannabis-related play has appeared in our reports several times; most recently on May 26th. At the time we mentioned that the stock was searching for support after a months-long downtrend, and that we felt the possibility of a rebound was forthcoming.

While it took several sessions to occur, MDCN finally found its legs yesterday with an 85% swing from .0013-.0024. It closed with strength, maintaining more than 50% of its daily gains on heavy volume, so we’ll definitely continue to observe the action here for the possibility of a multi-day run.

TapImmune, Inc. TPIV

Another stock that we tagged earlier this spring has been making serious moves. Just to update, we tagged TPIV on April 16th and at the time the stock was trading below .20. Since then, it has increased more than three-fold, now pushing its way up into the mid-.80’s.

This stock could produce ample bounce-play opportunities when it finally does consolidate off of this latest run-up, so we’ll put it on closer watch into next week.

Extended Watchlist:
CTIC, BLDP, CYTX, MNKD, CANF